PTPRD-AS1
gene geneOn this page
Summary
PTPRD-AS1 (PTPRD antisense RNA 1, HGNC:49753) is a long non-coding RNA gene on chromosome 9p24.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49753 |
| Approved symbol | PTPRD-AS1 |
| Name | PTPRD antisense RNA 1 |
| Location | 9p24.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000225706 |
| Ensembl biotype | lncRNA |
| Entrez | 101929407 |
| RNAcentral | URS000075D31A — lncRNA, 1334 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000430766, ENST00000447950, ENST00000665783, ENST00000666050, ENST00000846146
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000430766 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004273667 | 8859956 | 8861724 |
| ENSE00004273668 | 8857985 | 8858323 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 86.07.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8557 / max 84.0440, expressed in 501 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96025 | 1.3902 | 452 |
| 96023 | 0.2346 | 104 |
| 96026 | 0.1369 | 81 |
| 96024 | 0.0940 | 53 |
Top tissues by expression
229 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 86.07 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 83.09 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.58 | gold quality |
| spinal cord | UBERON:0002240 | 79.51 | gold quality |
| right coronary artery | UBERON:0001625 | 77.96 | gold quality |
| left ovary | UBERON:0002119 | 77.52 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.69 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.67 | gold quality |
| right ovary | UBERON:0002118 | 76.64 | gold quality |
| secondary oocyte | CL:0000655 | 76.55 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 76.38 | gold quality |
| caudate nucleus | UBERON:0001873 | 76.18 | gold quality |
| putamen | UBERON:0001874 | 75.91 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 75.20 | gold quality |
| cerebellum | UBERON:0002037 | 74.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.31 | gold quality |
| ovary | UBERON:0000992 | 74.11 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.74 | gold quality |
| hypothalamus | UBERON:0001898 | 73.39 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.37 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.82 | gold quality |
| left coronary artery | UBERON:0001626 | 72.57 | gold quality |
| amygdala | UBERON:0001876 | 72.05 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 71.95 | gold quality |
| ventricular zone | UBERON:0003053 | 71.87 | gold quality |
| substantia nigra | UBERON:0002038 | 71.32 | gold quality |
| coronary artery | UBERON:0001621 | 71.25 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.25 | gold quality |
| thoracic aorta | UBERON:0001515 | 70.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.91 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.